Cargando…

A New Vaccination Method Based on Phage NgoΦ6 and Its Phagemid Derivatives

Phagemid particles based on the Neisseria gonorrhoeae filamentous phage NgoΦ6 were used as a vaccine delivery system. We demonstrate that the host proteins incorporated into/associated with these particles can be encoded by chromosomal genes of the host bacterium or from plasmids able to replicate a...

Descripción completa

Detalles Bibliográficos
Autores principales: Piekarowicz, Andrzej, Kłyż, Aneta, Stein, Daniel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096494/
https://www.ncbi.nlm.nih.gov/pubmed/35572628
http://dx.doi.org/10.3389/fmicb.2022.793205
_version_ 1784705989793021952
author Piekarowicz, Andrzej
Kłyż, Aneta
Stein, Daniel C.
author_facet Piekarowicz, Andrzej
Kłyż, Aneta
Stein, Daniel C.
author_sort Piekarowicz, Andrzej
collection PubMed
description Phagemid particles based on the Neisseria gonorrhoeae filamentous phage NgoΦ6 were used as a vaccine delivery system. We demonstrate that the host proteins incorporated into/associated with these particles can be encoded by chromosomal genes of the host bacterium or from plasmids able to replicate as an autonomous entity in the phagemid host. Phagemid particles were prepared from three types of cells, namely, Salmonella enterica ser. Typhimurium [pBSKS::Φ6fm(ST)] containing phagemid genome as an autonomous plasmid, Haemophilus influenzae Rd containing phagemid [pBSKS::Φ6fm(Hin)] integrated into the chromosome, and S. enterica ser. Typhimurium [pMPMT6::Φ6fm(ST)] containing an additional plasmid, pE1 HCV, encoding the Hepatitis C virus envelope glycoprotein E1. Approximately 200 μg of purified phage particles was used to immunize rabbits. The phagemid particles prepared from these three strains all elicited a large amount of IgG antibodies that were able to recognize bacterial host cells and proteins, as determined by ELISA and FACS analysis. The amount of specific anti-S. enterica ser. Typhimurium, anti-H. influenzae, and anti-E1 HCV antibodies elicited by vaccination was 170 μg/ml for anti-Salmonella, 80 μg/ml for anti-H. influenzae, and 65 μg/ml for anti-E1 HCV. Taken in toto, these data suggest that classical phage display methods have underestimated the potential for filamentous phage as a novel immunogen delivery system.
format Online
Article
Text
id pubmed-9096494
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90964942022-05-13 A New Vaccination Method Based on Phage NgoΦ6 and Its Phagemid Derivatives Piekarowicz, Andrzej Kłyż, Aneta Stein, Daniel C. Front Microbiol Microbiology Phagemid particles based on the Neisseria gonorrhoeae filamentous phage NgoΦ6 were used as a vaccine delivery system. We demonstrate that the host proteins incorporated into/associated with these particles can be encoded by chromosomal genes of the host bacterium or from plasmids able to replicate as an autonomous entity in the phagemid host. Phagemid particles were prepared from three types of cells, namely, Salmonella enterica ser. Typhimurium [pBSKS::Φ6fm(ST)] containing phagemid genome as an autonomous plasmid, Haemophilus influenzae Rd containing phagemid [pBSKS::Φ6fm(Hin)] integrated into the chromosome, and S. enterica ser. Typhimurium [pMPMT6::Φ6fm(ST)] containing an additional plasmid, pE1 HCV, encoding the Hepatitis C virus envelope glycoprotein E1. Approximately 200 μg of purified phage particles was used to immunize rabbits. The phagemid particles prepared from these three strains all elicited a large amount of IgG antibodies that were able to recognize bacterial host cells and proteins, as determined by ELISA and FACS analysis. The amount of specific anti-S. enterica ser. Typhimurium, anti-H. influenzae, and anti-E1 HCV antibodies elicited by vaccination was 170 μg/ml for anti-Salmonella, 80 μg/ml for anti-H. influenzae, and 65 μg/ml for anti-E1 HCV. Taken in toto, these data suggest that classical phage display methods have underestimated the potential for filamentous phage as a novel immunogen delivery system. Frontiers Media S.A. 2022-04-28 /pmc/articles/PMC9096494/ /pubmed/35572628 http://dx.doi.org/10.3389/fmicb.2022.793205 Text en Copyright © 2022 Piekarowicz, Kłyż and Stein. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Piekarowicz, Andrzej
Kłyż, Aneta
Stein, Daniel C.
A New Vaccination Method Based on Phage NgoΦ6 and Its Phagemid Derivatives
title A New Vaccination Method Based on Phage NgoΦ6 and Its Phagemid Derivatives
title_full A New Vaccination Method Based on Phage NgoΦ6 and Its Phagemid Derivatives
title_fullStr A New Vaccination Method Based on Phage NgoΦ6 and Its Phagemid Derivatives
title_full_unstemmed A New Vaccination Method Based on Phage NgoΦ6 and Its Phagemid Derivatives
title_short A New Vaccination Method Based on Phage NgoΦ6 and Its Phagemid Derivatives
title_sort new vaccination method based on phage ngoφ6 and its phagemid derivatives
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096494/
https://www.ncbi.nlm.nih.gov/pubmed/35572628
http://dx.doi.org/10.3389/fmicb.2022.793205
work_keys_str_mv AT piekarowiczandrzej anewvaccinationmethodbasedonphagengoph6anditsphagemidderivatives
AT kłyzaneta anewvaccinationmethodbasedonphagengoph6anditsphagemidderivatives
AT steindanielc anewvaccinationmethodbasedonphagengoph6anditsphagemidderivatives
AT piekarowiczandrzej newvaccinationmethodbasedonphagengoph6anditsphagemidderivatives
AT kłyzaneta newvaccinationmethodbasedonphagengoph6anditsphagemidderivatives
AT steindanielc newvaccinationmethodbasedonphagengoph6anditsphagemidderivatives